Although mutations of p53 and K-Ras genes are commonly observed in NSCLC, numerous other driver mutations have been identified, such as EGFR, ALK, ERBB2, and BRAF[35]. This evidence concerns the gene ERBB2 and non-small cell lung carcinoma.